Nuno Mendonça
Chief Tech/Sci/R&D Officer at AC IMMUNE SA
Net worth: 18 835 $ as of 29/04/2024
Network origin in Nuno Mendonça first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
21
| Public Company | Pharmaceuticals: Major | 21 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nuno Mendonça via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SWISS LIFE HOLDING AG | Life/Health Insurance | Director/Board Member | |
| SCHINDLER HOLDING AG | Industrial Machinery | Director/Board Member | |
| HUBER+SUHNER AG | Telecommunications Equipment | Director/Board Member | |
| SCHWEIZERISCHE NATIONALBANK | Major Banks | Director/Board Member | |
| École Polytechnique Fédérale de Lausanne | College/University | Doctorate Degree | |
| University of Tilburg | College/University | Corporate Officer/Principal | |
| University of Lancaster | College/University | Undergraduate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of St. Gallen | College/University | Corporate Officer/Principal | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Executive Officer | |
| Technical University of Berlin | College/University | Graduate Degree | |
| University of Zurich | College/University | Undergraduate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| University of Bern | College/University | Undergraduate Degree | |
| University of Belgrade | College/University | Undergraduate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| DIMERIX LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Glenmark Pharmaceuticals Inc., USA
 Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Glenmark Pharmaceuticals USA, Inc. manufactures, markets, and distributes generic pharmaceutical products. It offers campral delayed-release tablets, differin gel, aclovate cream, aclovate topical ointment, ortho novum, and other related products. The company was founded in 2003 and is headquartered in Mahwah, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Abiogen Pharma SpA
 Abiogen Pharma SpA Miscellaneous Commercial ServicesCommercial Services Abiogen Pharma SpA manufactures and develops pharmaceutical products. The firm offers therapeutic drugs in the anti-inflammatory and painkiller, respiratory, bone metabolism, and dermatology areas. The company was founded by Massimo di Martino in 1997 and is headquartered in Pisa, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
HUBER+SUHNER (UK) Ltd.
 HUBER+SUHNER (UK) Ltd. Electronic Production EquipmentElectronic Technology HUBER+SUHNER (UK) Ltd. manufactures, imports, and sells electrical and optical connectivity components and accessories. It offers radio frequency and fiber optic products including antennas, assemblies, cables, connectors and adapters, lightning and EMP protectors, and resistive components. The company was founded on March 30, 1967 and is headquartered in Bicester, the United Kingdom. | Electronic Production Equipment | Director/Board Member | |
| World Demographic & Ageing Forum | Corporate Officer/Principal | ||
| Goizueta Business School-Emory | College/University | Undergraduate Degree | |
| Schweizerische Management Gesellschaft | Director/Board Member | ||
| Gebert Rüf Stiftung | Corporate Officer/Principal | ||
| Technical Institute of Jiangsu | College/University | Undergraduate Degree | |
| Centre for International Intellectual Property Studies | College/University | Graduate Degree | |
| Business School Lausanne | College/University | Masters Business Admin | |
| Network for Studies on Pensions Aging Retirement | Corporate Officer/Principal | ||
| Swiss Institute for Empirical Economic Research | Director/Board Member | ||
| Institute of Public Finance & Fiscal Law | Corporate Officer/Principal | ||
| Center for Disability & Integration | Corporate Officer/Principal | ||
| CESifo Research Network | Corporate Officer/Principal | ||
| Swiss Federal Commission for Economic Issues | Corporate Officer/Principal | ||
| Max Schmidheiny-Stiftung | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | Medical Distributors | Chief Executive Officer | |
Amal Therapeutics SA
 Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Biotechnology | Founder | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Oxford University Medical School | College/University | Doctorate Degree | |
| Swiss Institute For Intl Economics & Applied Economic Research | Chairman | ||
| Swiss Society of Economics & Statistics | President | ||
| Richard Büchner Foundation | Director/Board Member | ||
| Ernst & Young SA (Geneva) | Corporate Officer/Principal | ||
| Suva City Council | Corporate Officer/Principal | ||
| ViiV Healthcare Co. | Corporate Officer/Principal | ||
| Msizi Africa | Director/Board Member |
Statistics
International
| Switzerland | 26 |
| United States | 8 |
| United Kingdom | 5 |
| Netherlands | 3 |
| Germany | 3 |
Sectoral
| Consumer Services | 16 |
| Health Technology | 12 |
| Finance | 3 |
| Electronic Technology | 3 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 50 |
| Corporate Officer/Principal | 44 |
| Chief Tech/Sci/R&D Officer | 17 |
| Independent Dir/Board Member | 15 |
| Doctorate Degree | 13 |
Most connected contacts
- Stock Market
- Insiders
- Nuno Mendonça
- Company connections
